Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVS crawled date : 2022 - 05 - 05 save search
BioMarin Hires Pharmaceutical Industry Leaders in Marketing and Accounting to Fill Strategic Roles Supporting Company's Growth Plans
Published: 2022-05-05 (Crawled : 21:00) - investors.biomarin.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: -1.11%
H: 2.28%
C: -0.39%
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -10.81%
H: 0.0%
C: 0.0%
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
GSK | News | $40.995 1.0% 590K
|
Health Technology
|
| O: -1.32%
H: 0.75%
C: 0.2%
BMRN | $91.67 2.44% 570K
|
Health Technology
|
| O: -1.18%
H: 1.07%
C: -2.15%
growth
Global Asthma and COPD Drugs Market Report to 2030 - Opportunity Analysis and Industry Forecasts
Published: 2022-05-05 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: 0.18%
H: 0.46%
C: 0.46%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.98%
H: 0.0%
C: -2.72%
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: -0.86%
H: 1.57%
C: -0.42%
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: -0.39%
H: 0.15%
C: -1.07%
GSK | News | $40.995 1.0% 590K
|
Health Technology
|
| O: -0.98%
H: 0.0%
C: 0.0%
ABT | News | $107.565 0.46% 610K
|
Health Technology
|
| O: -0.73%
H: 0.12%
C: -1.61%
SNY | News | $47.5 0.74% 450K
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
AZN | News | $70.54 0.59% 1.7M
|
Health Technology
|
| O: -1.35%
H: 0.4%
C: -1.2%
report market drug
BeiGene Reports First Quarter 2022 Financial Results
Published: 2022-05-05 (Crawled : 12:00) - biospace.com/
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: -0.39%
H: 0.15%
C: -1.07%
BGNE | $140.43 7.25% 88K
|
Health Technology
|
| O: 0.98%
H: 7.7%
C: -2.09%
results
Incyte Announces European Commission Approval of Jakavi® (ruxolitinib) as the First Post-Steroid Treatment for Acute and Chronic Graft-Versus-Host Disease
Published: 2022-05-05 (Crawled : 10:00) - biospace.com/
NVS | News | $97.63 2.64% 1.6M
|
Health Technology
|
| O: -0.39%
H: 0.15%
C: -1.07%
INCY | $51.965 0.09% 590K
|
Health Technology
|
| O: 3.73%
H: 0.09%
C: -3.98%
jakavi treatment disease approval
Gainers vs Losers
| 88% | 12% |
Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M
|
AGBA | $2.355 88.4% 34M
|
Finance
EDBL | News | $6.75 79.52% 1.5M
|
CZOO | $8.77 75.75% 11M
|
MTC | $2.28 46.15% 2.6M
|
Technology Services
VNRX | $0.84 40.0% 2.6M
|
Health Technology
OPRT | News | $3.14 39.56% 7.6M
|
Finance
MLEC | $1.865 33.21% 2.4M
|
n/a
PALI | $6.37 29.21% 21M
|
Manufacturing
CMAX | $4.12 28.35% 65K
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.